• Conference
  • Earn CE
  • Free Samples
  • Magazine
  • Subscribe
  • Videos
    • Recent Quotes
    My Watchlist
    Indicators
    Dental Market Index
    Markets
    Stocks
    ETFs
    Tools
    Overview
    News
    Currencies
    International
    Treasuries

    Pyxis Oncology Inc (NQ: PYXS )

    3.930 UNCHANGED
    Streaming Delayed Price Updated: 4:00 PM EST, Nov 5, 2024 Add to My Watchlist
    Quote
    Overview Detailed Quote Charting Historical Prices
    News
    All News News Headlines Press Releases
    Research
    Quarterly Reports Insider Filings Other Filings

    Price and Volume

    Detailed Quote
    Volume 3
    Open 3.930
    Bid (Size) 3.850 (13)
    Ask (Size) 3.960 (1)
    Prev. Close 3.930
    Today's Range 3.930 - 3.930
    52wk Range 1.350 - 6.850
    Shares Outstanding N/A
    Dividend Yield N/A
    Chart for (: )
    Intraday 1 Week 1 Month 3 Month 1 Year 3 Year 5 Year

    Top News

    More News
    Pyxis Oncology to Participate in Two Upcoming Investor Conferences
    From Pyxis Oncology
    Via GlobeNewswire
    PYXS Stock Earnings: Pyxis Oncology Misses EPS for Q2 2024
    PYXS stock results show that Pyxis Oncology missed analyst estimates for earnings per share the second quarter of 2024. 
    Via InvestorPlace

    Performance

    YTD
    +90.78%
    +90.78%
    1 Month
    +15.59%
    +15.59%
    3 Month
    +16.62%
    +16.62%
    6 Month
    -10.27%
    -10.27%
    1 Year
    +125.86%
    +125.86%

    More News

    Read More
    Pyxis Oncology Provides Corporate Update and Reports Financial Results for Second Quarter 2024
    From Pyxis Oncology
    Via GlobeNewswire
    Pyxis Oncology to Participate in the BTIG Virtual Biotechnology Conference
    From Pyxis Oncology
    Via GlobeNewswire
    Pyxis Oncology: Q4 Earnings Insights
    Via Benzinga
    Pyxis Oncology Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
    From Pyxis Oncology
    Via GlobeNewswire
    Pyxis Oncology Expands Board of Directors with Appointment of Michael A. Metzger
    From Pyxis Oncology
    Via GlobeNewswire
    Pyxis Oncology to Participate in a Fireside Chat at the Jefferies Global Healthcare Conference
    From Pyxis Oncology
    Via GlobeNewswire
    PYXS Stock Earnings: Pyxis Oncology Beats EPS, Beats Revenue for Q1 2024
    Via InvestorPlace
    Pyxis Oncology Provides Corporate Update and Reports Financial Results for First Quarter 2024
    From Pyxis Oncology
    Via GlobeNewswire
    Pyxis Oncology to Present at the RBC Capital Markets Global Healthcare Conference
    From Pyxis Oncology
    Via GlobeNewswire
    Signet Jewelers, Dave & Buster's Entertainment, Blue Owl Capital And Other Big Stocks Moving Higher On Wednesday
    Via Benzinga
    Topics Stocks
    Exposures US Equities
    Why Ulta Beauty Shares Are Trading Lower By Around 14%? Here Are Other Stocks Moving In Wednesday's Mid-Day Session
    Via Benzinga
    Exposures Glyphosate
    Pyxis Oncology Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
    From Pyxis Oncology
    Via GlobeNewswire
    3 Biotech Stocks to Buy on the Dip: March 2024
    Via InvestorPlace
    Pyxis Oncology Obtains $8 Million Payment for the Sale of Royalty Rights
    From Pyxis Oncology
    Via GlobeNewswire
    Why FedEx Shares Are Trading Higher By Around 12%; Here Are 20 Stocks Moving Premarket
    Via Benzinga
    PYXS Stock Earnings: Pyxis Oncology Beats EPS for Q4 2023
    Via InvestorPlace
    Why FactSet Research Shares Are Trading Lower By Around 5%? Here Are Other Stocks Moving In Thursday's Mid-Day Session
    Via Benzinga
    Pyxis Oncology Provides Corporate Update and Reports Financial Results for Fourth Quarter and Full Year 2023
    From Pyxis Oncology
    Via GlobeNewswire
    From Six Figures to Seven: 3 Biotech Stocks Set to Make Millionaires
    Via InvestorPlace
    Today’s Biggest Pre-Market Stock Movers: 10 Top Gainers and Losers on Friday
    Via InvestorPlace
    Pyxis Oncology Expands Board of Directors with Appointment of Santhosh Palani, Ph.D., CFA
    From Pyxis Oncology
    Via GlobeNewswire
    Pyxis Oncology to Present at Leerink Global Biopharma Conference 2024
    From Pyxis Oncology
    Via GlobeNewswire
    Pyxis Oncology to Present New PYX-201, PYX-106 and PYX-102 Preclinical Data at AACR Annual Meeting
    From Pyxis Oncology
    Via GlobeNewswire
    Data & News supplied by www.cloudquote.io
    Stock quotes supplied by Barchart
    Quotes delayed at least 20 minutes.
    By accessing this page, you agree to the following
    Privacy Policy and Terms and Conditions.